24-week Placebo-controlled Trial of Flibanserin Once Daily in Premenopausal Women With Hypoactive Sexual Desire Disorder
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
This trial is designed to assess the safety and efficacy of flibanserin in the treatment of
premenopausal women with Hypoactive Sexual Desire Disorder (HSDD) that meets standard
diagnostic criteria. Efficacy for flibanserin will be assessed vs. a parallel placebo group.